• RV and SM

    Profs Vince and More Create New Antidote for Acetaminophen Poisoning

    UMN researchers create new antidote for acetaminophen poisoning

    Swati More, PhD, and Robert Vince, PhD, Professor and Director of the Center for Drug Design, discovered a potential new drug that works as an antidote to acetaminophen poisoning. It’s named ψ-Glutathione (Pseudo-Glutathione), similar to the naturally-occurring compound glutathione. A report of the compound’s efficacy was recently published in Chemical Research in ToxicologyRead More

  • Investigative Ophthalmology and Visual Science
    Investigative Ophthalmology and Visual Science

    Potential Early Detection of Alzheimer's Disease

    Researchers Test Early Alzheimer's Detection Method: Fox9
    U of M Researchers Find New Way to Detect Alzheimer's Using Eye Exam: KSTP
    Eye test for Alzheimer’s fares well in University of Minnesota study: Mineapolis/St. Paul Business Journal
  • Bob Vince

    Prof Vince Receives Antonin Holy Memorial Award from ISAR

    Prof Robert Vince has been awarded the Antonin Holy Memorial Award from the International Society for Antiviral Research (ISAR).

    Read More

  • Bats

    Prof Salomon's Research featured by the University

    Researchers from the University of Minnesota Center for Drug Design are getting closer to finding a solution to the problem of White Nose Syndrome affecting bat populations throughout the country. For the past six years, Christine Salomon, PhD, and her colleagues have been researching microorganisms living deep in the Soudan Mine in northeast Minnesota. Read More.

Message from the Director

Robert Vince

Robert Vince, PhD

The Center for Drug Design (CDD) was created to combine research and scholarship leading to the development of novel drugs for therapeutic applications, such as HIV, cancer, neurological diseases, dermatological agents, infectious diseases, novel processes, and medical devices. The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value  for our academic and research community.

Read the full message

Research Spotlight

Early Detection of Alzheimer's Disease Using an Eye Examination

For the first time, changes associated with early stages of Alzheimer's Disease were detected in live mice through color-shifts in the light reflected by the retina. For human trials, a simple eye test will be conducted by a trained health professional and several images of the retina will be acquired by an FDA approved camera. The procedure involved is non-invasive and does not depend on any extraneous agents. For more information about volunteering and compensation etc, please Click Here

Meet the Team:
Prof Robert Vince (Director, Center for Drug Design)
Prof Swati More (Assistant Professor, Center for Drug Design)
James Beach, PhD (Research Associate, Center for Drug Design, and CytoViva, Inc., Alabama)

Detecting Alzheimer's with an Eye Exam: Video

Detecting Alzheimer's with an Eye Exam